Innovative Medicines Canada
Ottawa/Toronto
Reporting to the Vice President, Market Access Policy, the Senior Director, Policy is an accomplished pharmaceutical policy expert with a proven record of designing ambitious policy programs, leading complex analytical work, and managing multi-stream policy initiatives. Working closely with colleagues across IMC, this individual develops evidence-informed policy and market access approaches that reflect a patient-first perspective and integrate with IMC’s broader policy, research, and trade agenda. A collaborative and trusted partner, the Senior Director engages with members, health system stakeholders, researchers, and international peers to advance solutions to access challenges including time-to-access, the value of medicines, ROI, cost-benefit analysis, and the broader impact of public policy. The role also works directly with pricing and reimbursement partners to improve procedures and accelerate access for Canadian patients.
